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DNA double-strand break repair through the RAD52
homologous recombination pathway in the yeast Sac-
charomyces cerevisiae requires, among others, the
RAD51, RAD52, and RAD54 genes. The biological impor-
tance of homologous recombination is underscored by
the conservation of the RAD52 pathway from fungi to
humans. The critical roles of the RAD52 group proteins
in the early steps of recombination, the search for DNA
homology and strand exchange, are now becoming ap-
parent. Here, we report the purification of the human
Rad54 protein. We showed that human Rad54 has
ATPase activity that is absolutely dependent on double-
stranded DNA. Unexpectedly, the ATPase activity ap-
peared not absolutely required for the DNA repair func-
tion of human Rad54 in vivo. Despite the presence of
amino acid sequence motifs that are conserved in a
large family of DNA helicases, no helicase activity of
human Rad54 was observed on a variety of different
DNA substrates. Possible functions of human Rad54 in
homologous recombination that couple the energy
gained from ATP hydrolysis to translocation along DNA,
rather than disruption of base pairing, are discussed.
DNA double-strand breaks (DSBs),1 generated by ionizing
radiation and endogenously produced radicals, are extremely
genotoxic lesions because as few as one or two unrepaired DSBs
can lead to cell death (1). Therefore, it is not surprising that
multiple pathways have evolved for the repair of DSBs (2, 3). Of
the two main pathways, DNA end-joining uses no or extremely
limited sequence homology to rejoin ends directly in a manner
that need not be error-free, whereas homologous recombination
requires extensive regions of DNA homology to repair DSBs
accurately using information on the undamaged sister chroma-
tid or homologous chromosome. The biological importance of
DSB repair through homologous recombination is underscored
by the conservation of its salient features from fungi to humans
(4, 5).
Genetic experiments have established a role for at least nine
genes of the yeast Saccharomyces cerevisiae in homologous
recombination (6). These so-called RAD52 epistasis group
genes include RAD50, RAD51, RAD52, RAD54, RAD55,
RAD57, RAD59, MRE11, and XRS2 (7–9). Mutations in any of
these genes result in ionizing radiation-sensitive phenotypes.
To date, proteins with amino acid sequence similarity to Rad50,
Rad51, Rad52, Rad54, and Mre11 have been identified in mam-
mals (3, 5). It is clear that the RAD52 homologous recombina-
tion pathway is functionally conserved from fungi to mammals.
Biochemical experiments have demonstrated that the yeast
and human Rad51 and Rad52 proteins perform key steps in
homologous recombination, the search for DNA homology, and
strand exchange, through similar mechanisms (9–20). Genetic
experiments have shown that human RAD54 is the functional
homolog of S. cerevisiae RAD54, because the human gene com-
plements certain DNA repair phenotypes of S. cerevisiae
rad54D cells (21). In addition, disruption of RAD54 in mouse
embryonic stem (ES) cells and chicken DT40 cells impairs
homologous recombination and results in ionizing radiation
sensitivity (22, 23).
In addition to the biochemical activities of Rad51 and Rad52,
the activities of other RAD52 group proteins, including Rad54,
Rad55, and Rad57, are becoming apparent (9–20, 24–27).
Here, we report the purification of the human Rad54 protein
(hRad54) from baculovirus-infected insect cells. Rad54 con-
tains seven amino acid sequence motifs that are conserved in a
large superfamily of proteins (28), including DNA helicases
involved in replication, recombination, and repair, such as the
Escherichia coli DnaB, RuvB, and UvrD proteins. In particular,
Rad54 belongs to the SWI2/SNF2 subfamily of ATPases (29).
We show that hRad54 has ATPase activity that is absolutely
dependent on double-stranded (ds) DNA. Unexpectedly, the
ATPase activity of hRad54 is not absolutely required for its
DNA repair function in vivo.
EXPERIMENTAL PROCEDURES
DNA Constructs—A cDNA construct encoding hRad54 containing a
polyhistidine amino-terminal tag (MGSSHHHHHHSSGLVPRGSH)
and a carboxyl-terminal hemagglutin tag (VTYPYDVPDYAS) was gen-
erated. The sequence of all DNA fragments produced by polymerase
chain reaction was confirmed by sequence analysis. For expression in
mouse ES cells, the cDNA was placed under control of the phosphoglyc-
erate kinase promoter. A construct expressing a tagged version of
hRad54 containing a single amino acid substitution at position 189 was
also generated. The invariant lysine residue at this position, which is in
the putative GKT Walker-type nucleotide binding motif, was changed to
an arginine residue (21). This protein is referred to as hRad54K189R.
ES Cell Culture—E14 ES cells were cultured and electroporated with
DNA constructs as described (30). The hRad54 expressing constructs
described above were electroporated into mRAD54 knockout ES line
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mRAD54307neo/pur (22). The disrupted mRAD54 alleles in this line con-
tain the neomycin- and puromycin-selectable markers, respectively.
The constructs were co-electroporated with a plasmid carrying the
hygromycin-selectable marker. Clones were selected as described (22)
and screened for hRad54 expression by immunoblot analysis.
The sensitivity of ES cells to increasing doses of ionizing radiation
and mitomycin C was determined by measuring their colony-forming
ability. After trypsinization and counting, various dilutions of the dif-
ferent ES cell lines were placed into gelatinized 60-mm dishes, and after
12–24 h, cells were incubated for 1 h in mitomycin C-containing me-
dium. Ionizing radiation sensitivity was determined by comparing the
colony-forming ability of the ES cell lines after irradiation with a 137Cs
source as described (22). Cloning efficiencies varied from 10 to 30%.
Cells were grown for 7 days, fixed, stained, and counted. All measure-
ments were performed in triplicate.
Purification of hRad54 Protein—The cDNAs encoding the tagged
hRad54 and hRad54K189R proteins were subcloned into pFastBac1
(BAC-TO-BAC Baculovirus Expression System, Life Technologies,
Inc.). The resulting plasmids were transformed into DH10Bac E. coli
cells to allow site-specific transposition into bacmid bMON14272. High
molecular weight recombinant bacmids were isolated and transfected
into Sf21 cells to produce virus stocks that were amplified as described
by the manufacturer. For protein production, 4.5 3 108 Sf21 cells were
infected with the recombinant baculoviruses at a multiplicity of infec-
tion of 10. Two days postinfection, cells were collected by low speed
centrifugation and washed twice with ice-cold phosphate-buffered sa-
line. For fractionation, the cells were lysed in eight packed cell volumes
of ice-cold Buffer A (20 mM Tris-HCl (pH 9.0), 300 mM NaCl, 1 mM
EDTA, 10% glycerol, 0.5% Nonidet P-40, 1 mM dithiothreitol, 0.1 mM
phenylmethylsulfonyl fluoride, 1 mg/ml leupeptin, 1 mg/ml antipain, 1
mg/ml pepstatin A, and 1 mg/ml chymostatin) for 30 min on ice. After
clarification of the lysate by centrifugation, the supernatant was neu-
tralized with four equivalents of packed cell volumes of ice-cold Buffer
B (100 mM Tris-HCl (pH 6.8), 300 mM NaCl, 1 mM EDTA, 10% glycerol,
0.5% Nonidet P-40, 1 mM dithiothreitol, 0.1 mM phenylmethylsulfonyl
fluoride, 1 mg/ml leupeptin, 1 mg/ml antipain, 1 mg/ml pepstatin A, and
1 mg/ml chymostatin). This crude extract (fraction I) was diluted with
0.5 volume of Buffer C (20 mM Hepes-KOH (pH 8.0), 0.2 mM EDTA, 2
mM MgCl2, 10% glycerol, 1 mM phenylmethylsulfonyl fluoride, and 5 mM
b-mercaptoethanol), loaded onto a phosphocellulose column (Whatman
P11), and equilibrated with Buffer C containing 0.2 M KCl, and after
washing, bound proteins were eluted with Buffer C containing 1.0 M
KCl (fraction II). Imidazole-HCl (pH 7.9) was added to a final concen-
tration of 2 mM to fraction II, which was subsequently incubated over-
night at 4 °C with 1 ml Ni21-nitrilotriacetate agarose (Qiagen). The
resin was washed with Buffer D (20 mM Tris-HCl (pH 7.5), 1 mM
b-mercaptoethanol, 0.05% Nonidet P-40, 10% glycerol, 500 mM KCl, and
20 mM imidazole-HCl (pH 7.9)). The hRad54 proteins were eluted with
Buffer E (20 mM Tris-HCl (pH 7.5), 1 mM b-mercaptoethanol, 0.05%
Nonidet P-40, 10% glycerol, 200 mM KCl, 1 mM EDTA, and 200 mM
imidazole-HCl (pH 7.9)) to yield fraction III. Fraction III was diluted
with three volumes of Buffer F (20 mM Hepes-KOH (pH 8.0), 1 mM
EDTA, 1 mM dithiothreitol, 10% glycerol, 0.01% Nonidet P-40) and
loaded onto a Mono S column (HR5/5) equilibrated with Buffer F con-
taining 0.2 M KCl. The column was washed with 5 column volumes of
equilibration buffer, and the hRad54 proteins were eluted with a 20-
column volume linear gradient from 0.2 to 1.0 M KCl in Buffer F. The
proteins (fraction IV) eluted around 0.4 M KCl. Aliquots were frozen in
liquid N2 and stored at 280 °C. The yield from 4.5 3 10
8 infected Sf21
cells varied between 60 and 120 mg of hRad54 protein.
ATPase Assay—Standard reaction mixtures contained 20 mM KPO4
(pH 7.0), 4 mM MgCl2, 40 mM KCl, 1 mM dithiothreitol, 100 mg/ml bovine
serum albumin, 200 mM ATP, 0.25 mCi of [g-32P]ATP (.5000 Ci/mmol),
45 mM DNA (concentration in nucleotides) and 0–100 ng of hRad54 or
hRadK189R protein in a 10-ml volume. Incubations were for 60 min at
30 °C. Reactions were initiated by the addition of DNA and MgCl2 to a
mixture containing the other components and terminated by the addi-
tion of EDTA to 167 mM. Released phosphate was separated from ATP
by thin-layer chromatography on polyethyleneimine cellulose using
0.75 M KH2PO4 as running buffer. Hydrolysis was quantitated with the
use of a Molecular Dynamics PhosphorImager. Background hydrolysis
observed in the absence of protein (;2%) was subtracted. Fig. 2 displays
the results of three or four independent experiments. To determine the
optimal pH of the reaction, the following buffers were used: Bis-Tris (pH
6.0), KPO4 (pH 7.0), and Tris (pH 7.5, 8.0, and 8.5) (see Table I).
DNA Helicase Assay—Partially dsDNA substrates were generated by
annealing oligonucleotides to M13mp18 viral DNA. The sequence of the
three oligonucleotides used was as follows: oligonucleotide a, 59-CCAA-
GCTTGCATGCCTGCAGGTCGACTCTAGAGGA; oligonucleotide b, 59-
TTTGCTGCCGGTCACCCAAGCTTGCATGCCTGCAGGTCGACTCTA-
GAGGA; and oligonucleotide c, 59-CCAAGCTTGCATGCCTGCAGGTC-
GACTCTAGAGGAAGGGGCCCATGGCTC. Annealing of oligonucleo-
tide a resulted in a 35-bp duplex, whereas annealing of oligonucleotides
b and c resulted in 15-nucleotide overhangs, either 59 or 39, in addition
to the 35-bp duplex region. The gel-purified oligonucleotides were 59-
end-labeled using T4 polynucleotide kinase and [g-32P]ATP and an-
nealed to M13mp18 viral DNA. Labeled substrates were separated from
labeled oligonucleotides by gel filtration through a Sepharose CL-4B
column.
A blunt-ended 79-bp dsDNA substrate was prepared by isolating the
XmaI-BglII restriction fragment from the hRAD54 cDNA (21) and
treating it with Klenow DNA polymerase in the presence of dTTP,
dGTP, dCTP, and [a-32P]dATP. This procedure resulted in incorpora-
tion of radiolabel in one of the two strands, indicated by the underlined
nucleotide in italics; 59-CCGGGTCTGGCGAGATGGTCAAAAGAA-
GACTTGCTATATCTACCGCCTGCTGTCTGCAGGGACCATTGAGGA-
GAAGATC.
Branched dsDNA substrates were made by annealing three partially
complementary oligonucleotides. The sequences of the oligonucleotides
(designated oligonucleotides 1–3) were the same as those used to inves-
tigate the DNA helicase activities of the E. coli RecG and T4 UvsW
proteins (31, 32). The arms of the branched structure were between 24
and 26 bp. The purification and annealing procedures were as described
(33). In the experiment shown, oligonucleotide 2 was 59-end-labeled
with the use of T4 polynucleotide kinase and [g-32P]ATP.
All DNA substrates were incubated for 60 min at 30 °C. Protein
concentrations were varied from 0 to 0.1 mM, and ATP concentrations
were varied from 0.2 to 2 mM. Reactions that were carried out in the
presence of an ATP regeneration system contained 40 mM phosphocre-
atine and 10 units/ml creatine phosphokinase. Reactions were termi-
nated by the addition of SDS and EDTA to 0.2% and 20 mM, respec-
tively. DNA species were separated by electrophoresis through
nondenaturing polyacrylamide gels that were dried and analyzed by
autoradiography.
RESULTS AND DISCUSSION
Purification of the Human Rad54 Protein—For the purpose
of purification, identification, and protein-protein interactions
studies, we constructed a cDNA expressing hRad54 containing
an amino-terminal polyhistidine tag and a carboxyl-terminal
hemagglutin tag. The addition of the tags did not interfere with
the biological function of hRad54. However, the presentation
and discussion of those results is deferred until Fig. 3. In
addition to the cDNA expressing wild-type tagged hRad54 pro-
tein, we generated a cDNA expression construct encoding a
tagged version of hRad54 containing a single amino acid sub-
stitution at position 189. This invariant lysine residue is in the
putative Walker A nucleotide binding motif and was changed to
an arginine residue using site-directed mutagenesis. The re-
sulting protein is referred to as hRad54K189R. For a number of
ATPases, including E. coli UvrD and S. cerevisiae Rad3, con-
version of the equivalent lysine residue into an arginine resi-
due severely impairs nucleotide triphosphate hydrolysis (34,
35). However, for UvrD and Rad3, nucleotide binding is unaf-
fected by the mutation, implying that the overall structure of
the protein remains intact.
For protein production, we placed both cDNAs under tran-
scriptional control of the polyhedrin promoter in recombinant
baculoviruses. These viruses were used to infect Sf21 cells. A
Coomassie-stained SDS-polyacrylamide gel containing crude
extract of the cells infected with the hRad54 encoding baculo-
virus is shown in Fig. 1, lane 2. Immunoblot analysis demon-
strated that the prominent band between the 107- and 68-kDa
molecular mass markers is the hRad54 protein (data not
shown). The extract was subsequently fractionated over phos-
phocellulose, Ni21-nitrilotriacetate agarose, and Mono S col-
umns as described under “Experimental Procedures.” Samples
of the hRad54-containing fractions were analyzed by electro-
phoresis through an SDS-polyacrylamide gel that was stained
with Coomassie Blue (Fig. 1). We estimate that the final
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hRad54 preparation had a purity of approximately 90%. A
sample of the final purification step of the hRad54K189R pro-
tein, which was produced and purified in exactly the same
manner as the wild-type protein, is shown in Fig. 1, lane 6.
The Human Rad54 Protein Is a dsDNA-dependent
ATPase—We tested whether the purified hRad54 protein could
hydrolyze ATP, because it contains Walker A and B amino acid
sequence motifs that are involved in ATP hydrolysis in a large
number of proteins (36). Increasing amounts of hRad54 protein
were incubated with ATP for 60 min at 30 °C. Released radio-
labeled phosphate was separated from nonhydrolyzed ATP by
thin layer chromatography, and the extent of hydrolysis was
quantitated (Fig. 2). In the absence of DNA, no significant
hydrolysis of input ATP was observed. The amount of input
ATP hydrolyzed varied between 0.2 and 1.0% and did not
increase with increasing protein concentration. Because the
ATPase activity of the SWI2/SNF2 protein is stimulated by
DNA (37), we included dsDNA in the reaction mixture. Fig. 2A
shows that inclusion of dsDNA is absolutely required for the
activation of the ATPase activity of hRad54. Recently, it was
shown that, like hRad54, the S. cerevisiae Rad54 protein also
possesses DNA-dependent ATPase activity (26). The observed
ATPase activity of hRad54 was not due to a contaminating
ATPase, because the identical preparation of hRad54K189R pro-
tein displayed no ATPase activity in the presence of dsDNA.
The lack of ATPase activity of hRad54K189R is not due to a
defect in DNA binding, because analysis of the DNA binding
properties showed that the wild-type and mutant proteins had
similar affinities for both ds and single-stranded (ss) DNA
(data not shown).
We next analyzed the effect of ssDNA on hRad54-mediated
ATP hydrolysis. M13 viral DNA also stimulated the hRad54
ATPase activity but to a lesser extent than dsDNA (Fig. 2A).
Because M13 viral DNA has a significant amount of secondary
structure and given the fact that dsDNA is such an effective
stimulator of the hRad54 ATPase activity, we tested whether
FIG. 1. Purification of the hRad54 protein. Coomassie-stained
SDS-polyacrylamide gel containing samples taken at different stages of
the hRad54 purification. A protein extract from Sf21 cells infected with
a baculovirus expressing hRad54 (CE) (lane 2) was fractionated sequen-
tially over phosphocellulose (P-cell) (lane 3), ni21-nitrilotriacetate aga-
rose (Ni-NTA) (lane 4), and Mono S (lane 5) columns. The hRad54K189R
protein was purified by the same method, and a sample of the final
preparation is shown in lane 6. Lanes 4–6 contain approximately 0.4 mg
of protein. The size of the protein molecular mass markers (M) in lane
1 is indicated in kDa.
FIG. 2. The hRad54 protein is a dsDNA-dependent ATPase. A,
the amount of ATP hydrolyzed by hRad54 and hRad54K189R after 60
min in the presence and absence of DNA is displayed as a function of
enzyme concentration. The amount of ATP in the reaction mixture at
time 0 was 2 nmol. ATPase assays were carried out as described under
“Experimental Procedures.” Reaction mixtures (10 ml) contained 0–100
ng of hRad54. B, as in A except that poly(dA), poly(dT), or hybridized
poly(dA-dT) was used as DNA cofactor. C, kinetics of ATP hydrolysis by
hRad54. Aliquots were removed from a reaction mixture at the indi-
cated time points, and the extent of ATP hydrolysis by hRad54 in the
presence of dsDNA was measured. The concentration of hRad54 in the
reaction corresponded to the 15-ng data point in A.
Purification and Characterization of the Human Rad54 Protein28294
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ssDNA that does not form secondary structure can stimulate
the ATPase activity. Therefore, we incubated increasing
amounts of hRad54 with poly(dA) or poly(dT). Both homopoly-
mers were unable to activate the ATPase activity of hRad54
(Fig. 2B). The measured ATPase activity in the presence of
poly(dA) and poly(dT) was 0.1–0.5% and 0.3–0.9%, respec-
tively. However, when the two polymers were allowed to form
base pairs before addition to the reaction mixture, they did
efficiently activate the hRad54 ATPase activity (Fig. 2B). We
conclude that hRad54 is a dsDNA-dependent ATPase and that
the substitution of amino acid 189 from lysine to arginine
results in loss of the ATPase activity.
The rate of ATP hydrolysis by hRad54 was determined in the
presence of dsDNA (Fig. 2C). The turnover rate was found to be
;800 mol of ATP min21 mol21 hRad54. Thus, hRad54 is a more
active ATPase than other DNA-dependent ATPases involved in
recombination, such as human Rad51, a DNA strand exchange
protein that exhibits ssDNA-stimulated ATPase activity with a
turnover rate of 0.16 min21 (14). The hRad54 ATPase exhibits
a turnover rate within the range of DNA helicases involved in
recombination and repair, such as RuvB (4.2 min21) and UvrD
(10,000 min21) (35, 38).
We varied a number of reaction conditions to determine some
requirements for hRad54-mediated ATP hydrolysis. The re-
sults of these experiments are summarized in Table I. In ad-
dition to dsDNA, divalent cations were found to be essential for
ATP hydrolysis. The topology of the dsDNA cofactor is not
critical, because duplex linear and supercoiled DNA stimulated
the ATPase activity of hRAD54 to similar levels. Like ssDNA,
RNA did not activate the hRad54 ATPase activity. Optimal
catalytic activity was obtained at pH 7.0 and at a temperature
of 25–30 °C.
Amino- and Carboxyl-terminal Tags Do Not Interfere with
the Biological Function of hRad54—Before analyzing other
activities of the hRad54 protein, we determined whether the
tags on the protein would interfere with its function. mRAD54
knockout cells were electroporated with the cDNA constructs
expressing tagged hRad54 and hRad54K189R proteins. For each
construct, 24 clones were analyzed for protein expression by
immunoblot analysis using anti-hRad54 antibodies. A number
of independent cell lines were identified that expressed either
tagged wild-type or mutant protein. Expression levels, which
did not vary much between the different clones, ranged from
one-half to twice the level found in wild-type ES cells. An
example of an immunoblot containing protein extracts from
mRAD54 knockout ES cell lines expressing tagged versions of
the wild-type and mutant hRad54 proteins is shown in Fig. 3A.
We have shown previously that mRAD54 knockout ES cells
are sensitive to ionizing radiation and the DNA cross-linking
agent mitomycin C. In addition, the mRad54 protein could
rescue the mitomycin C sensitivity (22). Therefore, we tested
whether the mRAD54 knockout cell lines that expressed the
tagged wild-type and mutant hRad54 proteins could rescue the
g-ray and mitomycin C sensitivity. Fig. 3B shows that the
wild-type tagged hRad54 completely corrects the g-ray sensi-
tivity caused by the mutations in mRAD54. The efficiency of
the rescue did not depend on the expression level of hRad54
because a cell line expressing one-half the level of Rad54 found
in wild-type cells gave similar results (data not shown).
Interestingly, expression of the tagged hRad54K189R pro-
tein resulted in a partial rescue of the g-ray sensitivity (Fig.
3B). As above, the expression level of hRad54K189R was not
critical to the observed effect because an independently ob-
tained cell line, expressing twice the level of Rad54 compared
with wild-type cells, gave similar results (data not shown).
Tagged hRad54 also rescued the mitomycin C sensitivity of
mRAD54 knockout cells (Fig. 3C). Again, expression of tagged
hRad54K189R led to a partial rescue. Similar results were ob-
tained with independent clones expressing different levels of
tagged hRad54 and hRad54K189R, respectively (data not
shown). We conclude that the amino-terminal polyhistidine tag
and the carboxyl-terminal hemagglutin tag do not interfere
with the function of the hRad54 protein.
Rad54, together with SWI2/SNF2 and Mot1, belongs to the
SNF2/SWI2 family of DNA-stimulated ATPases (29). The
ATPase activity of the SNF2/SWI2 and Mot1 proteins is essen-
tial for their functions in vivo (37, 39). Surprisingly, we found
that the hRad54K189R protein, which is completely deficient in
ATPase activity (Fig. 2A), is partially functional in vivo (Fig. 3,
B and C). Thus, ATP hydrolysis can, at least in part, be uncou-
pled from other biological activities of hRad54, implying that
other properties of the protein are also important for its func-
tion. One of those functions could be in contributing to the
formation of multiprotein complexes. The absence of one of the
components of such complexes might be more detrimental than
the presence of a crippled component. For example, the absence
of one of the components of the ERCC1/XPF structure-specific
endonuclease causes instability of the other component (40,
41). Because genetic and physical interactions have been de-
tected among many of the RAD52 group genes and proteins (25,
26, 42–48), it is likely that these proteins function in the
context of complex protein machines. Similar to the observation
presented here for hRad54, an ATPase-deficient mutant of the
transcription-coupled nucleotide excision repair protein CSB,
which is part of a multiprotein complex, is partially active in
vivo as well (49).
Analysis of hRad54 Activity in DNA Helicase Assays—Be-
cause the hRad54 protein contains seven amino acid sequence
motifs that are found in many DNA helicases and because it
has DNA-dependent ATPase activity, we tested whether
hRad54 could use the energy gained from ATP hydrolysis to
disrupt base pairing in duplex DNA. We tested five distinct
DNA substrates in helicase assays, because DNA helicases
differ in their substrate specificity. The first set of three sub-
strates consisted of M13 viral DNA to which oligonucleotides
were annealed. One substrate contained a 35-bp duplex region,
TABLE I
ATPase activity of the hRad54 protein
The ATPase activity of 20 ng of hRad54 was determined under
standard conditions described under “Experimental Procedures,” with
the exception of the indicated variable. An ATPase activity of 100%
corresponds to hydrolysis of 65% of input ATP.
Variable Relative ATPase activity
%
Divalent cation
None ,1
Mg21 100
Mn21 109
pH
6.0 21
7.0 100
7.5 83
8.0 44
8.5 14
Temperature
25 °C 124
30 °C 100
37 °C 34
Nucleic acid cofactor
None ,1
Supercoiled DNA 100
Linear dsDNA 90
M13 viral DNA 48
Poly(dT) ,1
Poly(dA) ,1
RNA ,1
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whereas the others were forked substrates that contained 15-
nucleotide noncomplementary regions either 59 or 39 of the
35-bp duplex region. The hRad54 protein appeared unable to
displace the oligonucleotide from the M13 DNA (Fig. 4A). The
hRad54 protein concentration was varied over the same range
as was used for the ATPase assays shown in Fig. 2 (data not
shown). The lack of helicase activity cannot be explained by a
rapid depletion of ATP, because the inclusion of an ATP regen-
eration system in the reaction mixture did not result in detect-
able helicase activity (data not shown). In contrast, the UvrD
protein efficiently displaced the oligonucleotide from all three
substrates (Fig. 4A). Our results with hRad54 are consistent
with those obtained with the S. cerevisiae Rad54 protein, which
also displays no helicase activity on substrates containing non-
complementary ssDNA tails (26).
In E. coli, the RecBCD DNA helicase plays a pivotal role in
processing DSBs during recombination (50). Its substrate is a
dsDNA end. Given the involvement of Rad54 in recombina-
tional DSB repair, it was important to test whether the protein
exhibited DNA helicase activity on a blunt-ended dsDNA sub-
strate (Fig. 4B). We were unable to detect any helicase activity
of hRad54 on this substrate, even in the presence of an ATP
regeneration system and over a wide range of hRad54 concen-
tration. In contrast, UvrD efficiently separated the strands this
FIG. 3. hRad54 rescues the g-ray and mitomycin C sensitivity
of mRAD54 knockout ES cells. A, immunoblot of protein extracts
from wild-type (1/1) and mRAD54 knockout (–/–) ES cells. mRAD54
knockout ES cells were stably transfected with the wild-type (hRAD54)
or mutant (hRAD54K189R) cDNA constructs expressing the tagged pro-
teins. Protein extracts from the indicated cell lines were separated on
an 8% SDS-polyacrylamide gel, transferred to nitrocellulose, and incu-
bated with affinity-purified anti-hRad54 antibodies. Detection was with
alkaline phosphatase-coupled goat anti-rabbit antibodies. The positions
of the 107- and 68-kDa protein molecular mass markers are indicated
on the left. The position of the mammalian Rad54 protein is indicated on
the right. B, clonogenic survival assay of the wild-type, mRAD54 knock-
out, and cDNA-transfected ES cell lines after treatment with increasing
doses of g-rays. The percentage of surviving cells as measured by their
colony-forming ability is plotted as a function of the g-ray dose. Details
of the protocol are described under “Experimental Procedures.” The
S.E. values are not indicated, except for the dose of 8 Gy, because for all
other doses they were within 4–20%. C, clonogenic survival assay of the
same cell lines shown in B after treatment with increasing concentra-
tions of mitomycin C.
FIG. 4. The hRad54 protein displays no activity in DNA heli-
case assays. A, DNA helicase assay using a 35-nucleotide (nt) oligomer
annealed to M13 viral DNA as a substrate. The three oligonucleotides
used were either completely complementary or contained a 15-nucleo-
tide 59 or 39 noncomplementary region, in addition to the 35 comple-
mentary nucleotides. Oligonucleotides were labeled with 32P at their
59-end before annealing to the viral DNA. DNA substrates (;20 pmol)
were incubated with 100 ng of hRad54 or hRad54K189R protein in the
presence of ATP for 60 min at 30 °C. Products were separated by
electrophoresis through a nondenaturing polyacrylamide gel and visu-
alized by autoradiography. The positions of the substrate and the ra-
diolabeled reaction products are indicated to the right of the autoradio-
gram. The asterisk denotes the position of the 32P label. The three
control reactions shown either lacked hRad54 protein (untreated), were
heated to 95 °C (DT), or contained UvrD protein (UvrD). B, DNA heli-
case assay using a 79-bp linear dsDNA as substrate. The DNA sub-
strate (;20 pmol) was incubated with 100 ng of hRad54 or hRad54K189R
protein for 60 min at 30 °C. Reactions were carried out in the absence
or presence of ATP or in the presence of an ATP regeneration system
(ATP reg.), as indicated. They were analyzed as described in A, and the
same control reactions were included. The positions of the substrate
and the radiolabeled reaction product are indicated to the left of the
autoradiogram. C, DNA helicase assay using a branched dsDNA as
substrate. The experiment was performed as described in B, except that
the DNA substrate was a branched dsDNA containing arms of 24–26 bp
that was generated by annealing three partially complementary
oligonucleotides.
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DNA substrate (Fig. 4B).
Some DNA helicases, such as the E. coli RecG protein, which
is involved in recombination and repair, are inactive on forked
duplexes and blunt-ended duplex DNA substrates, such as
those tested in Fig. 4, A and B. Instead, the RecG protein
unwinds substrates containing a three-way duplex branch (31).
However, even with this DNA substrate, no helicase activity of
hRad54 was detected (Fig. 4C).
On the basis of its amino acid sequence, Rad54 belongs to a
superfamily of DNA-dependent ATPases (28). Many superfam-
ily members have DNA helicase activity. Although the experi-
ments presented above do not rule out the possibility that
hRad54 has DNA helicase activity, they make it less likely.
Possibly, the seven conserved amino acid sequence motifs that
define the superfamily provide a general activity, of which
helicase activity could be a subset (51). This more general
activity could be the ability to translocate along DNA at the
expense of ATP hydrolysis (52). By using the energy gained
from ATP hydrolysis translocation of Rad54 along DNA might
be useful in at least three stages of homologous recombination.
First, in light of the interaction between the Rad54 and Rad51
proteins (26, 45, 47, 48), translocation of Rad54 might provide
processivity to Rad51-mediated DNA strand exchange. Com-
pared with the E. coli RecA protein, hRad51 makes short het-
eroduplex joints (9). A role for Rad54 in extending these joints
is consistent with the recent demonstration that S. cerevisiae
Rad54 stabilizes D-loops (26). Providing processivity to joint
formation might be especially important in the context of chro-
matin. Second, translocation of hRad54 could be to promote
branch migration of Holliday junctions to extend heteroduplex
DNA, in a manner that is analogous to the molecular motor
function of the RuvB protein. Third, an alternative function of
Rad54 could be in removing the Rad51 protein from joint mol-
ecules, formed between the two recombining partners after the
initiation of recombination, in order to prevent reversal of the
reaction. In this respect, the action of Rad54 would be analo-
gous to that of the Mot1 protein, which disrupts protein DNA-
complexes involved in transcription (35). The availability of
purified hRad54 protein facilitates testing of the possible func-
tions of the protein described above.
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